[
    {
        "title": "The Unmatched History Of The Jeep Wrangler - TopSpeed",
        "description": "The Unmatched History Of The Jeep Wrangler  TopSpeed",
        "published date": "Wed, 16 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3LnRvcHNwZWVkLmNvbS90aGUtdW5tYXRjaGVkLWhpc3Rvcnktb2YtdGhlLWplZXAtd3JhbmdsZXIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Early Intervention With Nutrient Supplementation May Be Beneficial ... - Pharmacy Times",
        "description": "Early Intervention With Nutrient Supplementation May Be Beneficial ...  Pharmacy Times",
        "published date": "Tue, 15 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L2Vhcmx5LWludGVydmVudGlvbi13aXRoLW51dHJpZW50LXN1cHBsZW1lbnRhdGlvbi1tYXktYmUtYmVuZWZpY2lhbC10by1wYXRpZW50cy13aXRoLWFsemhlaW1lci1kaXNlYXNl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Individuals With Sustained or Increasing Opioid Use Were Older ... - Pharmacy Times",
        "description": "Individuals With Sustained or Increasing Opioid Use Were Older ...  Pharmacy Times",
        "published date": "Tue, 15 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikgFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L2luZGl2aWR1YWxzLXdpdGgtc3VzdGFpbmVkLW9yLWluY3JlYXNpbmctb3Bpb2lkLXVzZS13ZXJlLW9sZGVyLWhhZC1tb3JlLWNvbW9yYmlkaXRpZXMtaGlnaGVyLXVzZS1vZi1vdGhlci1kcnVnc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Common Cold Virus Associated With Rare Blood Clotting Disorder - Pharmacy Times",
        "description": "Common Cold Virus Associated With Rare Blood Clotting Disorder  Pharmacy Times",
        "published date": "Tue, 15 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvY29tbW9uLWNvbGQtdmlydXMtYXNzb2NpYXRlZC13aXRoLXJhcmUtYmxvb2QtY2xvdHRpbmctZGlzb3JkZXLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Elranatamab in relapsed or refractory multiple myeloma: phase 2 ... - Nature.com",
        "description": "Elranatamab in relapsed or refractory multiple myeloma: phase 2 ...  Nature.com",
        "published date": "Tue, 15 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvczQxNTkxLTAyMy0wMjUyOC050gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]